Rho-kinase inhibitor prevents hepatocyte damage in acute liver injury induced by carbon tetrachloride in rats.
暂无分享,去创建一个
M. Omata | H. Ikeda | Y. Yatomi | K. Fujiwara | T. Tomiya | N. Watanabe | Y. Kume | Kazuaki Tejima | Takako Nishikawa | M. Arai | N. Ohtomo | C. Arai | Yukio Kume | Natsuko Ohtomo
[1] Y. Kikuchi,et al. A Rho-kinase inhibitor, fasudil, prevents development of diabetes and nephropathy in insulin-resistant diabetic rats. , 2007, The Journal of endocrinology.
[2] A. Nishiyama,et al. Involvements of Rho-kinase and TGF-beta pathways in aldosterone-induced renal injury. , 2006, Journal of the American Society of Nephrology : JASN.
[3] M. Menger,et al. Protective effect of fasudil, a Rho‐kinase inhibitor, on chemokine expression, leukocyte recruitment, and hepatocellular apoptosis in septic liver injury , 2006, Journal of leukocyte biology.
[4] M. Halks-Miller,et al. Fasudil, a Rho-Kinase Inhibitor, Attenuates Angiotensin II–Induced Abdominal Aortic Aneurysm in Apolipoprotein E–Deficient Mice by Inhibiting Apoptosis and Proteolysis , 2005, Circulation.
[5] C. Guguen-Guillouzo,et al. TNFα‐mediated extracellular matrix remodeling is required for multiple division cycles in rat hepatocytes , 2005, Hepatology.
[6] 塩谷 聡子. Involvement of Rho-kinase in cold ischemia-reperfusion injury after liver transplantation in rats , 2005 .
[7] J. Liao,et al. Inhibition of Rho-Kinase Leads to Rapid Activation of Phosphatidylinositol 3-Kinase/Protein Kinase Akt and Cardiovascular Protection , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[8] Y. Maehara,et al. Involvement of Rho-Kinase in Cold Ischemia-Reperfusion Injury after Liver Transplantation in Rats , 2004, Transplantation.
[9] A. Fujimura,et al. Partial protective effect of Y-27632, a Rho kinase inhibitor, against hepatic ischemia-reperfusion injury in rats. , 2004, European journal of pharmacology.
[10] K. Kaibuchi,et al. Long-Term Treatment With a Rho-Kinase Inhibitor Improves Monocrotaline-Induced Fatal Pulmonary Hypertension in Rats , 2004, Circulation research.
[11] W. Bao,et al. Inhibition of Rho-kinase protects the heart against ischemia/reperfusion injury. , 2004, Cardiovascular research.
[12] J. S. Sidhu,et al. Phenobarbital responsiveness as a uniquely sensitive indicator of hepatocyte differentiation status: requirement of dexamethasone and extracellular matrix in establishing the functional integrity of cultured primary rat hepatocytes. , 2004, Experimental cell research.
[13] Y. Inoue,et al. Involvement of Rho/Rho kinase pathway in regulation of apoptosis in rat hepatic stellate cells. , 2003, American journal of physiology. Gastrointestinal and liver physiology.
[14] S. Arii,et al. Therapeutic significance of Y-27632, a Rho-kinase inhibitor, on the established liver fibrosis. , 2003, The Journal of surgical research.
[15] M. Crow,et al. Central involvement of Rho family GTPases in TNF-alpha-mediated bovine pulmonary endothelial cell apoptosis. , 2003, Biochemical and biophysical research communications.
[16] Anne J. Ridley,et al. ROCKs: multifunctional kinases in cell behaviour , 2003, Nature Reviews Molecular Cell Biology.
[17] T. Asahara,et al. Prevention of ischemia–reperfusion-induced hepatic microcirculatory disruption by inhibiting stellate cell contraction using rock inhibitor1 , 2003, Transplantation.
[18] Z. Radisavljevic. Nitric oxide suppression triggers apoptosis through the FKHRL1 (FOXO3A)/ROCK kinase pathway in human breast carcinoma cells , 2003, Cancer.
[19] Y. Yamaoka,et al. Reduction of hepatic ischemia/reperfusion-induced injury by a specific ROCK/Rho kinase inhibitor Y-27632. , 2003, The Journal of surgical research.
[20] S. Todo,et al. A novel inhibitor of Rho-associated protein kinase, Y-27632, ameliorates hepatic ischemia and reperfusion injury in rats. , 2003, Surgery.
[21] Y. Inoue,et al. Antiproliferative property of sphingosine 1-phosphate in rat hepatocytes involves activation of Rho via Edg-5. , 2003, Gastroenterology.
[22] Xianwu Li,et al. Inhibition of Protein Geranylgeranylation and RhoA/RhoA Kinase Pathway Induces Apoptosis in Human Endothelial Cells* , 2002, The Journal of Biological Chemistry.
[23] S. Hosoda,et al. Anti-anginal Effect of Fasudil, a Rho-Kinase Inhibitor, in Patients With Stable Effort Angina: A Multicenter Study , 2002, Journal of cardiovascular pharmacology.
[24] T. Nakamura,et al. Inhibitory effect of Y-27632, a ROCK inhibitor, on progression of rat liver fibrosis in association with inactivation of hepatic stellate cells. , 2001, Journal of hepatology.
[25] H. Nawata,et al. A selective ROCK inhibitor, Y27632, prevents dimethylnitrosamine-induced hepatic fibrosis in rats. , 2001, Journal of hepatology.
[26] J. Bertoglio,et al. Caspase-3-mediated cleavage of ROCK I induces MLC phosphorylation and apoptotic membrane blebbing , 2001, Nature Cell Biology.
[27] E. Sahai,et al. Membrane blebbing during apoptosis results from caspase-mediated activation of ROCK I , 2001, Nature Cell Biology.
[28] M. Morimatsu,et al. Role of Rho-Associated Kinase in Neointima Formation After Vascular Injury , 2001, Circulation.
[29] P. Tangkijvanich,et al. Wound‐induced migration of rat hepatic stellate cells is modulated by endothelin‐1 through rho‐kinase‐mediated alterations in the acto‐myosin cytoskeleton , 2001, Hepatology.
[30] H. Ikeda,et al. Lysophosphatidic acid enhances collagen gel contraction by hepatic stellate cells: association with rho-kinase. , 2000, Biochemical and biophysical research communications.
[31] H. Nagumo,et al. Rho kinase inhibitor HA-1077 prevents Rho-mediated myosin phosphatase inhibition in smooth muscle cells. , 2000, American journal of physiology. Cell physiology.
[32] S. Seki,et al. ROCK inhibitor Y-27632 attenuates stellate cell contraction and portal pressure increase induced by endothelin-1. , 1999, Biochemical and biophysical research communications.
[33] K. Hornbrook,et al. Serum and liver concentrations of tumor necrosis factor α and interleukin-1β following administration of carbon tetrachloride to male rats , 1998 .
[34] Y. Ikawa,et al. Evidence of hepatocyte apoptosis in rat liver after the administration of carbon tetrachloride. , 1998, The American journal of pathology.
[35] Jason C. Mills,et al. Apoptotic Membrane Blebbing Is Regulated by Myosin Light Chain Phosphorylation , 1998, The Journal of cell biology.
[36] K. Hornbrook,et al. Serum and liver concentrations of tumor necrosis factor alpha and interleukin-1beta following administration of carbon tetrachloride to male rats. , 1998, Toxicology letters.
[37] K. Fujisawa,et al. p160ROCK, a Rho‐associated coiled‐coil forming protein kinase, works downstream of Rho and induces focal adhesions , 1997, FEBS letters.
[38] David R. Kaplan,et al. Regulation of Neuronal Survival by the Serine-Threonine Protein Kinase Akt , 1997, Science.
[39] X. Q. Chen,et al. The p160 RhoA-binding kinase ROK alpha is a member of a kinase family and is involved in the reorganization of the cytoskeleton , 1996, Molecular and cellular biology.
[40] Kozo Kaibuchi,et al. Regulation of Myosin Phosphatase by Rho and Rho-Associated Kinase (Rho-Kinase) , 1996, Science.
[41] K. Takakura,et al. Effect of AT877 on cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Results of a prospective placebo-controlled double-blind trial. , 1992, Journal of neurosurgery.
[42] I. Sipes,et al. Reactive oxygen species in the progression of CCl4-induced liver injury. , 1991, Advances in experimental medicine and biology.
[43] K. Fujiwara,et al. Hepatic sinusoidal cell destruction in the development of intravascular coagulation in acute liver failure of rats , 1989, The Journal of pathology.
[44] T. Nakamura,et al. Increased survival of rat hepatocytes in serum-free medium by inhibition of a trypsin-like protease associated with their plasma membranes. , 1984, Experimental cell research.
[45] T. Nakamura,et al. Identification of trypsin inhibitor in bovine pituitary extracts as a survival factor for adult rat hepatocytes in primary culture. , 1984, Journal of Biochemistry (Tokyo).
[46] T. Nakamura,et al. Role of serum in maintenance of functional hepatocytes in primary culture. , 1982, Journal of biochemistry.
[47] P. Seglen. Preparation of rat liver cells. 3. Enzymatic requirements for tissue dispersion. , 1973, Experimental cell research.
[48] P. Seglen. Preparation of rat liver cells. II. Effects of ions and chelators on tissue dispersion. , 1973, Experimental cell research.